euHeart
Personalised and intergrated cardiac care: nPatient-specific Cardiovascular Modelling and Simulation for In Silico Disease Understanding and Management
| Coordinatore | PHILIPS TECHNOLOGIE GMBH
Organization address
address: High Tech Campus (HTC36.p.005) 36 contact info |
| Nazionalità Coordinatore | Germany [DE] |
| Totale costo | 19˙143˙221 € |
| EC contributo | 13˙900˙000 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2007-2 |
| Funding Scheme | CP |
| Anno di inizio | 2008 |
| Periodo (anno-mese-giorno) | 2008-06-01 - 2012-11-30 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
PHILIPS TECHNOLOGIE GMBH
Organization address
address: High Tech Campus (HTC36.p.005) 36 contact info |
DE (Eindhoven) | coordinator | 0.00 |
| 2 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF contact info |
NL (AMSTERDAM) | participant | 0.00 |
| 3 |
BERLIN HEART GMBH
Organization address
address: WIESENWEG 10 contact info |
DE (BERLIN) | participant | 0.00 |
| 4 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Organization address
address: 101 Rue de Tolbiac contact info |
FR (PARIS) | participant | 0.00 |
| 5 |
INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET EN AUTOMATIQUE
Organization address
address: Domaine de Voluceau, Rocquencourt contact info |
FR (LE CHESNAY Cedex) | participant | 0.00 |
| 6 |
Karlsruher Institut fuer Technologie
Organization address
address: Kaiserstrasse contact info |
DE (Karlsruhe) | participant | 0.00 |
| 7 |
KING'S COLLEGE LONDON
Organization address
address: Strand contact info |
UK (LONDON) | participant | 0.00 |
| 8 |
LIFETEC GROUP BV
Organization address
address: DEN DOLECH 2 - WH 3.116 contact info |
NL (EINDHOVEN) | participant | 0.00 |
| 9 |
PHILIPS IBERICA SA
Organization address
address: CALLE MARIA DE PORTUGAL 1 contact info |
ES (MADRID) | participant | 0.00 |
| 10 |
PHILIPS MEDICAL SYSTEMS NEDERLAND BV
Organization address
address: VEENPLUIS 4-6 contact info |
NL (BEST) | participant | 0.00 |
| 11 |
SERVICIO MADRILENO DE SALUD
Organization address
address: PLAZA CARLOS TRIAS BERTRAN contact info |
ES (MADRID) | participant | 0.00 |
| 12 |
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Organization address
address: University Offices, Wellington Square contact info |
UK (OXFORD) | participant | 0.00 |
| 13 |
THE UNIVERSITY OF SHEFFIELD
Organization address
address: FIRTH COURT WESTERN BANK contact info |
UK (SHEFFIELD) | participant | 0.00 |
| 14 |
UNIVERSITAETSKLINIKUM HEIDELBERG
Organization address
address: IM NEUENHEIMER FELD 672 contact info |
DE (HEIDELBERG) | participant | 0.00 |
| 15 |
UNIVERSITAT POMPEU FABRA
Organization address
address: PLACA DE LA MERCE 10-12 contact info |
ES (BARCELONA) | participant | 0.00 |
| 16 |
UNIVERSITE DE RENNES I
Organization address
address: RUE DU THABOR contact info |
FR (RENNES CEDEX) | participant | 0.00 |
| 17 |
VOLCANO EUROPE SA / NV
Organization address
address: EXCELSIORLAAN 41 contact info |
BE (ZAVENTEM) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Cardiovascular disease (CVD) has a significant impact on the European society in terms of mortality, morbidity and allied healthcare costs. The opportunity of multi-scale modelling spanning, sub-cellular level up to whole heart is to improve CVD outcomes by providing a consistent, biophysically-based framework for the integration of the huge amount of fragmented and inhomogeneous data currently available. However, multi-scale models have not yet been translated into clinical environments mainly due to the difficulty of personalising biophysical models. The challenge of the euHeart project is to directly address this need by combining novel ICT technologies with integrative multi-scale computational models of the heart in clinical environments to improve diagnosis, treatment planning and interventions for CVD.nnTo meet this challenge we will bring together leading European physiological modelling and cardiac groups to develop, integrate and clinically validate patient-specific computational models of the cardiac physiology and disease-related processes. The main outcome of euHeart will be an open source framework for the description and representation of normal and pathological multi-scale and multi-physics cardiovascular models, using the international encoding standards. In addition, a library of innovative tools for the execution of the biophysical simulations, the personalisation of the models and the automated analysis of multi-modal images are developed.nnEvidence of clinical benefit will be collected to quantify potential impact for a number of significant CVD's namely, heart failure, cardiac rhythm disorder, coronary artery disease and valvular and aortic diseases. Each of the selected clinical applications provides a complementary focus for the resulting integrated model of cardiac fluid-electro-mechanical function. The consortium contains a mix of academic leadership, clinical sites, and industrial partners ensuring exploitation of the wealth of models